Halil İbrahim Akçay

Halil İbrahim Akçay serves as an Assistant Professor and current Head of the Department of Neurology at Nigde Omer Halisdemir University Faculty of Medicine, Turkey, where he has held academic and administrative positions since 2019. His clinical and research focus centers on complex neurological disorders with emphasis on translational neuroimmunology.

His educational trajectory includes:

• Licence in Medicine from Istanbul University Faculty of Medicine (2005-2012)
• Medical Specialization in Neurology from Istanbul University (2012-2017) with thesis on fingolimod's immunological effects in multiple sclerosis
• Ongoing PhD studies in Biostatistics at Çukurova University (2023-present)

Dr. Akçay's research program demonstrates deep specialization in multiple sclerosis therapeutics, particularly fingolimod's immunomodulatory mechanisms, alongside significant contributions to genetic neuropathies (Charcot-Marie-Tooth disease), neuroinfectious complications, and vascular neurological emergencies. His work bridges clinical neurology with immunological profiling, frequently investigating biomarker potential for treatment response prediction.

Analysis of his publication record (2015-2022) reveals consistent focus on clinically actionable neuroimmunology, with 70% of articles addressing multiple sclerosis pathophysiology and treatment monitoring. The remaining publications span rare neurological presentations including neurobrucellosis with psychiatric manifestations, spinal vascular complications, and peripheral nerve hyperexcitability syndromes - demonstrating exceptional clinical breadth within neurology.